Liver transplant bleeding study pulled before starting
Disease control
Terminated
This study was designed to see if a new concentrated fibrinogen product works better than the standard one for controlling bleeding in liver transplant patients. It planned to enroll adults having a cadaveric liver transplant who were at risk for low fibrinogen levels. However, t…
Phase: PHASE4 • Sponsor: Ezeldeen Abuelkasem • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC